MRO Magazine

Celanese Presents Innovative Medical Polymers for Next Generation Medical Devices at Pharmapack


February 3, 2016
By Business Wire News

DALLAS & PARIS

Celanese Corporation (NYSE: CE), a global technology and specialty materials company, will present “Innovative Materials: Choices for Next Generation Medical Devices” at the 2016 Drug Delivery and Packaging Pharmapack Europe in Paris, France.

“Our broad portfolio of medical materials is expanding the possibilities of drug delivery design and allowing more innovative devices to be developed that are promoting better patient care,” said Wendy Johnson, medical marketing manager for Celanese. “Our customers are creating easy-to-use, comfortable drug delivery devices with our latest medical polymer, Hostaform® MT® SlideX™ POM. This thermoplastic polymer delivers excellent wear and slip properties for smooth-sliding drug delivery device parts that improve patient comfort.”

Celanese’s engineering and ethylene vinyl acetate (EVA) medical polymer portfolio delivers expanded device design capabilities that are backed by world-class materials expertise from conception to market implementation.

Hostaform® MT® SlideX™ POM, a thermoplastic polymer, will be highlighted as the latest material innovation that is improving patient comfort. This tribologically-modified polymer delivers excellent wear and slip properties and is suitable for use in a wide range of drug delivery devices, such as dry powder inhalers, pressurized metered dose inhalers (pMDIs), and injection devices.

Celanese Learning Lab Presentation
Topic: Innovative Materials: Choices for Next Generation Medical Devices
Date: Thursday, February 11, 2016
Time: 9:45 a.m. Central European Time
Presenters: Wendy Johnson, Customer & Application Marketing Manager, Medical

Celanese materials experts will be meeting with Pharmapack attendees at Booth 858 on February 10-11, 2016. For more information about Celanese’s medical and pharmaceutical materials solutions, visit healthcare.celanese.com.

About Celanese

Celanese Corporation is a global technology leader in the production of differentiated chemistry solutions and specialty materials used in most major industries and consumer applications. Our two complementary business cores, Acetyl Chain and Materials Solutions, use the full breadth of Celanese’s global chemistry, technology and business expertise to create value for our customers and the corporation. As we partner with our customers to solve their most critical business needs, we strive to make a positive impact on our communities and the world through The Celanese Foundation. Based in Dallas, Celanese employs approximately 7,000 employees worldwide and had 2015 net sales of $5.7 billion. For more information about Celanese and our product offerings, visit www.celanese.com or our blog at www.celaneseblog.com.

All registered trademarks are owned by Celanese International Corporation or its affiliates.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company or any of its customers will realize these benefits or that these expectations will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Other risk factors include those that are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Celanese
Investor Relations

Chuck Kyrish, +1-972-443-4574
chuck.kyrish@celanese.com
or
Media Relations – Global
W. Travis Jacobsen, +1-972-443-3750
william.jacobsen@celanese.com
or
Media Relations Asia (Shanghai)
Helen Zhang, +86 21 3861 9279
lan.zhang@celanese.com
or
Media Relations Europe (Germany)
Jens Kurth, +49(0)69 45009 1574
j.kurth@celanese.com